Vascular calcification in chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Vascular Biology

Background:

• Vascular calcification (VC) is highly prevalent in chronic kidney disease (CKD) patients.
• Pathogenesis involves traditional and non-traditional cardiovascular risk factors, including dialysis duration and mineral metabolism disorders.
• Key mechanisms include vascular smooth muscle cell transformation and impaired regulation of inhibitors.

Purpose of the Study:

• To review the pathophysiological mechanisms, detection methods, and management strategies for VC in CKD.
• To highlight the role of non-traditional risk factors and VC inhibitors.
• To inform the development of novel therapeutic agents for reducing VC and improving cardiovascular outcomes.

Main Methods:

• Literature review of pathophysiological mechanisms of VC in CKD.
• Summary of current methods for VC detection, including arterial stiffness evaluation.
• Overview of existing and potential management strategies for VC.

Main Results:

• VC pathogenesis is multifactorial, involving mineral metabolism disorders and altered cell phenotypes.
• VC contributes significantly to increased arterial stiffness, left ventricular hypertrophy, and cardiovascular mortality in CKD.
• Current treatments focus on mineral and bone disorder management, but novel agents targeting VC mechanisms are needed.

Conclusions:

• VC is a major contributor to cardiovascular morbidity and mortality in CKD patients.
• A comprehensive understanding of VC mechanisms, promoters, and inhibitors is essential for therapeutic advancements.
• Future research should focus on developing targeted therapies to mitigate VC and improve cardiovascular health in CKD.